Overview

  • Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route. 

  • His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.

  • He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University). 

  • An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).

  • Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.

  • During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant. 

  • Field of Expertise

  • Coronary Interventions
  • Fellowship & Membership

  • FSCAI
  • FESC
  • Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran

    Fellowship & Membership

  • FSCAI
  • FESC
  • Overview

  • Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route. 

  • His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.

  • He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University). 

  • An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).

  • Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.

  • During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant. 

  • Field of Expertise

  • Coronary Interventions
  • Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran

    Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Overview

  • Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route. 

  • His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.

  • He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University). 

  • An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).

  • Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.

  • During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant. 

  • Fellowship & Membership

  • FSCAI
  • FESC
  • Field of Expertise

  • Coronary Interventions
  • Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran

    Field of Expertise

  • Coronary Interventions
  • Fellowship & Membership

  • FSCAI
  • FESC
  • Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
  • Overview

  • Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route. 

  • His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.

  • He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University). 

  • An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).

  • Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.

  • During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant. 

    Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.
  • Fellowship & Membership

  • FSCAI
  • FESC
  • Field of Expertise

  • Coronary Interventions
  • Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
  • Overview

  • Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route. 

  • His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.

  • He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University). 

  • An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).

  • Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.

  • During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant. 

    Talks & Publications

  • Correlation of duration of diabetes with severity of coronary artery disease inpatients with Type II diabetes mellitus . T.D Shah, R S Venkariya, R L Kamath M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Correlation of duration of diabetes with severity of coronary artery disease in patients with Type II DM - T D Shah, R S Vekariya, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K Kamath
  • Role of Tolvaptan in congestive heart failure patients : A novel therapeutic approatch – T D shah, S T Varghese, R L Kamath, M N bhat, N D Pai, R U Bhat, P K Kamath
  • Congeital coronary artery to pulmonary artery fistula : An unseen Villain – T D Shah, V G Karnik, M P Srinvasan, R L Kamath, M N Bhat, N D Pai, R U Bhat, P K, Kamath
  • Short term outcome in chronic heart failure with the additions of Hydralazine to standard antifailure therapy – A prospective study – Dr Shijie Varghese
  • Risk factor profile of young patients with acute coronary syndrome - Dr. Ritesh Vakariya
  • Comparative study of intra coronary SNP and Nikoran for treatment of flow phenomenon during PCI in patients with acute coronary syndrome. – Dr Siddesh
  • Short term outcome (1 year followup study) in a severe CAD (Syntax score 722) with difference therapeutic strategies (percutaneous coronary intervention V/S coronary artery bypass graft V/S medical management ) – Dr Vidur Karnik .
  • Echocardiographic assessment of strain in myocardial infarct after revascularization and after 1 month , a followup study
  • An echocardiographic assessment and comparison of right ventricular function in acute inferior wall MI and within one month of index event patients after undergoing successful revascularization procedure.
  • Severity of coronary artery disease in type 2 DM:does the timing matter – Mukun P, Srinivasan, Padmanabh K Kamath, Narayan M Bhat, Narasimha D Pai, Rajesh U Bhat, Tejas D Shah, Anish Singhal, Chakrapani Mahabala
  • Correlation between insulin resistance and severity of coronary artery disease in non – diabetes, Rohit Shenoy, Rajesh Bhat, Mukund Srinivasan, Chakrapani Mahabala, Unnikrishnan Bhaskaran
  • Overview

  • Dr. Rajesh Bhat U is an Associate Professor and the best cardiologist in Mangalore at KMC Hospital. He is well trained in PTCA (percutaneous coronary intervention) and has performed around 3000 such procedures including PAMI (primary angioplasty) with a majority of them being through the radial route. 

  • His fields of expertise are angiograms (performed over 7000 angiograms), coronary interventions and non-coronary interventions, such as BMV/PTMC and pacemaker insertions.

  • He completed his basic education at Bhatkal, Mysore and Udupi. He graduated with (MBBS) from the Adichunchangiri Institute of Medical Sciences, Bellur (Mysore University) and an MD (General Medicine) from KMC Mangalore (Manipal University). 

  • An alumnus of Narayana Hrudayalaya, he is quite proficient in pediatric cardiology including pediatric echo (neonatal) and interventions (ASD/PDA closure).

  • Dr. Rajesh Bhat U began his medical career as a physician at Bhatkal and worked there from 1998 to 2004. Following his advanced training in cardiology (DNB-Cardiology) at Narayana Hrudayalaya, Bangalore, he worked as a resident interventional cardiologist in the same hospital for 5 years. This was followed by a successful stint at K.S. Hegde Hospital, where he worked as a Consultant Interventional Cardiologist for 4 years.

  • During his medical career, Dr. Bhat has participated in several workshops, CMEs and conferences. He has been involved in major international studies – TRUST, SPIRE, APOLLO and OASIS-6 both as a student and a consultant. 

  • Fellowship & Membership

  • FSCAI
  • FESC
  • Field of Expertise

  • Coronary Interventions
  • Languages Spoken

  • Kannada
  • Hindi
  • English
  • Tulu
  • Awards & Achievements

  • Sub- Investigator in “Effects of Fondaparineux on Mortality and Reinfarction in Patients with Acute ST-nSegment Elevation Myocardial Infarctions; The OASIS –VI Study Group” at Narayana Hrudayalaya.
  • Co-investigator in Multinational Double Blind Randomized study titled “Treprostinil IV for Untreated Symptomatic PAH-Trial (TRUST) Study” conducted by Asian Clinical trials, Hyderabad and United Therapeutic Corporation, USA.
  • Principal investigator at Mangalore site for Multinational Double Blind study “Aliskiren Prevention Of Later Life Outcomes (APOLLO)”.
  • Principal Investigatorat Mangalore site for Pfizer sponsored for SPIRE: Studies of PCSK9 (BOCOCIZUMAB )Inhibition and the Reduction of vascular Events – SPIRE 1 & SPIRE2.

Blogs

Appointment
Health Check
Home Care
Contact Us
Write to COO
Review Us
Call Us